Hui Xie

Dr. Hui Xie


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2023 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Open access
PDF file
XXXianpeng Xu
Xianpeng Xu
XLXinghong Liu
Xinghong Liu
JLJiongke Li
Jiongke Li
XDXinxing Deng
Xinxing Deng
TDTianrong Dai
Tianrong Dai
HXHui Xie
Hui Xie
Many potential environmental risk factors, protective factors, and biomarkers of AR have been published, but so far, the strength and consistency of their evidence are unclear. We conducted a comprehensive review of environmental risk, protective factors, and biomarkers for AR to establish the evidence hierarchy. We systematically searched Embase, PubMed, Cochrane Library, and Web of Science electronic database from inception to December 31, 2022. We calculated summary effect estimate (odds ratio (OR), relative risk (RR), hazard ratio (HR), and standardized mean difference (SMD)), 95% confidence interval, random effects p value, I2 statistic, 95% prediction interval, small study effects, and excess significance biases, and stratification of the level of evidence. Methodological quality was assessed by AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews 2). We retrieved 4478 articles, of which 43 met the inclusion criteria. The 43 eligible articles identified 31 potential environmental risk factors (10,806,206 total population, two study not reported), 11 potential environmental protective factors (823,883 total population), and 34 potential biomarkers (158,716 total population) for meta-analyses. The credibility of evidence was convincing (class I) for tic disorders (OR = 2.89, 95% CI 2.11–3.95); and highly suggestive (class II) for early-life antibiotic use (OR = 3.73, 95% CI 3.06–4.55), exposure to indoor dampness (OR = 1.49, 95% CI 1.27–1.75), acetaminophen exposure (OR = 1.54, 95% CI 1.41–1.69), childhood acid suppressant use (OR = 1.40, 95% CI 1.23–1.59), exposure to indoor mold (OR = 1.66, 95% CI 1.26–2.18), coronavirus disease 2019 (OR = 0.11, 95% CI 0.06–0.22), and prolonged breastfeeding (OR = 0.72, 95% CI 0.65–0.79). This study is registered in PROSPERO (CRD42022384320).

7 January 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
XJXiaohua Jin
Xiaohua Jin
XXXianpeng Xu
Xianpeng Xu
JWJingjing Wang
Jingjing Wang
XLXinghong Liu
Xinghong Liu
XDXinxing Deng
Xinxing Deng
HXHui Xie
Hui Xie
Objective: To systematically evaluate the association between hypertension and hearing loss.Methods: A standardized search for studies on hypertension and hearing loss in PubMed, Embase, Scopus, and Web of Science was performed using subject terms, free terms, and keyword combinations for the period of library construction to March 2024. Meta-analysis was performed using RevMan 5.4 and STATA 18.0.Results: A total of 12 studies were included, assessing 594,676 participants. The combined OR using the random effects model was 1.849 (95% CI: 1.549, 2.208). Heterogeneity in this analysis was high (I2 = 98%, p < 0.1), and by sensitivity analysis we found that the heterogeneity may have originated from 3 studies, the removal of which significantly reduced the heterogeneity and had a small effect on the effect size [OR (95%CI): 1.893 (1.834, 1.953), I2 = 0.0%, p = 0.465].Conclusion: Hypertension may be one of the risk factors for hearing loss. Identification of hypertension can help in early assessment and management of hearing loss risk.Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42023460001.

20 October 2022 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
XXXianpeng Xu
Xianpeng Xu
TGTao Guo
Tao Guo
ZLZifeng Liu
Zifeng Liu
PCPeng Chen
Peng Chen
YZYing Zhang
Ying Zhang
HXHui Xie
Hui Xie
Objective: To comprehensively summarize the evidence on the preferences, expectations, and values of hypertension management and treatment in hypertensive patients. Methods: From inception through January 2022, PubMed, Embase, Web of Science, EBSCO, and China National Knowledge Infrastructure were searched for studies with hypertension value, preference, or expectation. A qualitative retrospective analysis was performed. Results: A total of 24 studies involving 8701 participants were included. Although studies on the preferences of hypertensive patients are difficult to standardize, considerable convergence has occurred: 1) Patients preferred treatment regimens with lower incidence of comorbidities, faster response, lower cost, more frequent blood pressure monitoring, fewer side effects, and more convenient medication. 2) Patients have a crucial role in the treatment, and their physicians are expected to develop a shared patient-centered decision-making model. Conclusion: The results of this systematic review demonstrated that side effects, cost, and convenience are important factors for patients when selecting a treatment regimen for hypertension. Patients often obtain hypertension information from their physicians and prefer shared patient-centered decision-making.

15 October 2014 in Trials
Verified
Journal Article
Open access
PDF file
HXHui Xie
Hui Xie
XLXinrong Li
Xinrong Li
JLJiaqin Lai
Jiaqin Lai
YZYanan Zhou
Yanan Zhou
CWCaiying Wang
Caiying Wang
LJLiang Jiao
Liang Jiao
Acupuncture has been used in China to treat tinnitus for a long time. There is debate as to whether or not De Qi is a key factor in achieving the efficacy of acupuncture. However, there is no sufficient evidence obtained from randomized controlled trials to confirm the role of De Qi in the treatment of acupuncture for tinnitus. This study aims to identify the effect of De Qi for patients who receive acupuncture to alleviate tinnitus by a prospective, double-blind, randomized, sham-controlled trial. This study compares two acupuncture groups (with or without manipulation) in 292 patients with a history of subjective tinnitus. The trial will be conducted in the Teaching Hospital of Chengdu University of Traditional Chinese Medicine. In the study, the patients will be randomly assigned into two groups according to a computer-generated randomization list and assessed prior to treatment. Then, they will receive 5 daily sessions of 30 minutes each time for 4 consecutive weeks and undergo a 12-week follow-up phase. The administration of acupuncture follows the guidelines for clinical research on acupuncture (WHO Regional Publication, Western Pacific Series Number 15, 1995), and is performed double-blind by physicians well-trained in acupuncture. The measures of outcome include the subjective symptoms scores and quantitative sensations of De Qi evaluated by Visual Analog Scales (VAS) and the Chinese version of the ‘modified’ Massachusetts General Hospital Acupuncture Sensation Scale (C-MMASS). Furthermore, adverse events are recorded and analyzed. If any subjects are withdrawn from the trial, intention-to-treat analysis (ITT) and per-protocol (PP) analysis will be performed. The key features of this trial include the randomization procedures, large sample and the standardized protocol to evaluate De Qi qualitatively and quantitatively in the treatment of acupuncture for tinnitus. The trial will be the first study with a high evidence level in China to assess the efficacy of De Qi in the treatment of tinnitus in a randomized, double-blind, sham-controlled manner. Chinese Clinical Trial Registry: ChiCTR-TRC-14004720 (6 May 2014).

27 November 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JZJingqi Zhang
Jingqi Zhang
MZMengqi Zhao
Mengqi Zhao
YYYa Yu
Ya Yu
YZYining Zeng
Yining Zeng
MSMeiyi Sun
Meiyi Sun
HXHui Xie
Hui Xie
Introduction: Allergic rhinitis (AR) is a globally prevalent immune-mediated disorder. While the “gut-nasal axis” suggests that gut microbiota metabolites can modulate AR, the specific molecular networks and key targets involved remain poorly defined. This study aimed to systematically explore the molecular connections between gut microbiota-derived metabolites and AR, and to identify potential therapeutic targets. Methods: We performed an integrative multi-omics analysis using databases including gutMGene and GeneCards to identify overlapping genes. Summary-data-based Mendelian randomization (SMR) was used to investigate associations between genetic variation, DNA methylation, gene expression, and AR. Single-cell analysis was conducted to examine gene expression patterns in the AR nasal mucosa. Finally, upstream analysis, target prediction, and molecular docking were employed to identify key metabolites, protein targets, and candidate drugs. Results: We identified 20 overlapping genes, highlighting a significant association between AR and core inflammatory mediators like IL6, TNF, IL1B, and IL4R. SMR analysis indicated that genetic and epigenetic regulation within the interleukin gene family is closely linked to AR. Single-cell analysis revealed distinct expression patterns of these core genes in the nasal mucosa. Upstream analysis connected these findings to specific microbiota-derived metabolites, notably indole-3-propionic acid and succinate. MPO and PTGDR2 were identified as key potential targets, and Fevipiprant and Zileuton were proposed as candidate drugs. Conclusion: This study provides the first systematic exploration of the “gut-nasal” metabolic axis in AR at a multi-level molecular network level, offering novel perspectives on the disease's underlying mechanisms. The identified targets and candidate drugs provide a valuable foundation for developing new therapeutic strategies, warranting further experimental validation for potential clinical translation.

18 November 2022 in Frontiers in Neurology
Verified
Journal Article
Open access
XXXianpeng Xu
Xianpeng Xu
HXHui Xie
Hui Xie
ZLZifeng Liu
Zifeng Liu
TGTao Guo
Tao Guo
YZYing Zhang
Ying Zhang
Background: To systematically summarize the evidence for the efficacy of acupuncture in tinnitus treatment, we assessed the methodological quality, reporting quality, and evidence quality of systematic reviews/meta-analyses (SRs/MAs) of acupuncture in the treatment of tinnitus.Methods: From inception to March 2022, we conducted a detailed and comprehensive search of eight electronic databases in Chinese and English. The Assessing the Methodological Quality of Systematic Reviews 2 (AMSTAR-2), the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) were used to assess methodological quality, reporting quality and evidence quality for inclusion in SRs/MAs, respectively.Results: Fourteen published SRs/MAs met the inclusion criteria and were included in the study. Eleven studies reported that acupuncture was effective in treating tinnitus, and three studies reported that no firm conclusions could be drawn about the effectiveness of acupuncture in treating tinnitus. The results of the AMSTAR-2 assessment showed that the methodological quality of the included studies was relatively low in general, with one being moderate quality and the rest being very low quality. The PRISMA checklist evaluation results showed that no studies fully report checklists, with protocol registration and search strategies being the main reporting weaknesses. The GRADE assessment showed that no results were high-quality evidence, 17 results were moderate-quality evidence, 25 results were low-quality evidence, and 12 results were very low-quality evidence.Conclusion: Acupuncture seems to be a positive and effective treatment for tinnitus. However, the methodological quality and quality of evidence for SRs/MAs in the included studies were generally low, and this result must be viewed with caution. Therefore, more high-quality, large-scale, multi-center randomized controlled trials are needed in the future to verify the effectiveness of acupuncture in the treatment of tinnitus.